BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:28 PM
 | 
Sep 17, 2012
 |  BC Extra  |  Clinical News

Targacept restructures after discontinuing TC-5619 for ADHD

Targacept Inc. (NASDAQ:TRGT) discontinued development of TC-5619 to treat ADHD and said it will implement a further reduction in headcount as well as limit its investment in its neuronal nicotinic receptor pipeline until the search for a new CEO is completed. The news sent shares of Targacept sliding $0.54 (11%) to $4.31 on Monday. The company discontinued...

Read the full 280 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >